Furthermore, for the outcomes CVD and CHD, there was evidence for stronger associations in the two studies that measured OPG in plasma [27,29] than in the other studies that had analysed serum (P = 0.005 and 0.018). This evidence concerns the gene TNFRSF11B and coronary artery disorder.